Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The serotonin syndrome]

L Broude1, I Iancu, O T Dolberg

  • 1Psychiatric Division, Chaim Sheba Medical Center, Tel Hashomer.

Harefuah
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a maleic acid-based material to selectively solid-phase extract basic compounds from environmental samples.

Journal of chromatography. A·2021
Same author

How to manage obsessive-compulsive disorder (OCD) under COVID-19: A clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology.

Comprehensive psychiatry·2020
Same author

From self-induced to perceived errors - A generalized over-monitoring activity in obsessive-compulsive disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2019
Same author

Manifesto for a European research network into Problematic Usage of the Internet.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2018
Same author

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study.

Acta psychiatrica Scandinavica·2018
Same author

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder.

Acta psychiatrica Scandinavica·2018
Same journal

[Tennis Elbow Among Players].

Harefuah·2026
Same journal

[Internal Medicine - My Mission].

Harefuah·2026
Same journal

[Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

Harefuah·2026
Same journal

[Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

Harefuah·2026
Same journal

[Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

Harefuah·2026
Same journal

[Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

Harefuah·2026
See all related articles

Selective serotonin reuptake inhibitors (SSRIs) increase the risk of serotonin syndrome, a condition linked to 5HT1A receptor stimulation. Early diagnosis and treatment are crucial for managing this potentially serious adverse drug reaction.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Clinical Medicine

Background:

  • Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed antidepressants.
  • Increased SSRI use correlates with a higher incidence of adverse drug reactions.
  • Serotonin syndrome is a known, albeit rare, complication of serotonergic medications.

Observation:

  • Two cases of serotonin syndrome are presented: a 29-year-old woman and a 69-year-old man.
  • The syndrome is characterized by symptoms such as agitation, confusion, tremor, fever, and shivering.
  • These symptoms arise from the overstimulation of serotonin 5HT1A receptors.

Findings:

  • The reported cases highlight the clinical presentation of serotonin syndrome in patients using SSRIs.
  • The syndrome's pathophysiology involves excessive serotonergic activity, particularly via 5HT1A receptors.

Related Experiment Videos

  • Specific considerations for patients with obsessive-compulsive disorder (OCD) experiencing this syndrome are discussed.

    • Implications:

    • Emphasizes the critical need for prompt recognition and intervention for serotonin syndrome.
    • Highlights the importance of physician awareness regarding SSRI-induced toxicity.
    • Informs clinical practice for managing patients on SSRIs, especially those with comorbid conditions like OCD.